ImmunOs Therapeutics AG’s $11 Million Series C Financing Round

Marco Zingaro
Tagged:

VISCHER advised ImmunOs Therapeutics AG on all legal issues related to the transaction.ImmunOs Therapeutics AG, a biopharmaceutical company leveraging its unique immune system modulating HLA-based technology…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Marco Zingaro

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here